What Happens to Estrogen Levels When You Start TRT?
What Happens to Estrogen Levels When You Start TRT? June 14, 2026 10 min read Testosterone Replacement Therapy Table of
June 21, 2026
No Comments
You started semaglutide, saw real progress in the first few months, and then something changed. The scale stopped moving. Your appetite feels similar to before. You are doing everything the same, but the results have stalled. If this sounds familiar, you are not alone and you are not doing anything wrong.
A weight loss plateau on semaglutide is one of the most common experiences among patients in medical weight loss programs. It does not mean the medication has stopped working. It does not mean you have failed. And it does not mean progress is over. What it means is that your body has adapted, and that adaptation requires a response.
This guide explains why plateaus happen during semaglutide treatment, what your body is actually doing during a stall, and what practical steps you and your provider can take to start seeing results again.
A weight loss plateau is defined as a period of four weeks or longer without meaningful progress on the scale despite continued adherence to treatment. A single week without weight loss is not a plateau. Normal fluctuations in water retention, hormonal cycles, and digestive content can produce short-term stalls that are not clinically significant.
A genuine plateau persists over multiple weeks, is not explained by changes in water retention or other temporary factors, and occurs in the context of continued medication adherence and reasonable lifestyle habits.
Understanding this definition matters because many people label a two-week stall as a plateau and make premature adjustments that are not necessary. Patience in the short term, combined with honest assessment of adherence factors, is the right first response before concluding that a true plateau has occurred.
Semaglutide is a highly effective medication, but it operates within the constraints of human physiology. Several mechanisms explain why weight loss tends to slow after an initial period of strong progress.
As you lose weight, your resting metabolic rate decreases. Your body burns fewer calories at rest at a lower body weight than it did at your starting weight. This metabolic adaptation is proportional to the amount of weight lost and is a normal physiological response that applies to all weight loss methods, not just semaglutide.
What this means practically is that the caloric deficit that produced weight loss at the start of treatment may no longer be sufficient to produce ongoing loss at your current weight. The same food intake that created a meaningful deficit earlier in treatment may now be closer to maintenance.
As total body weight decreases, the proportion of lean muscle mass relative to total body weight can influence metabolism. Muscle tissue is metabolically active and burns more calories at rest than fat tissue. If weight loss has included some muscle loss alongside fat loss, this can further reduce resting metabolic rate.
This is one of the reasons resistance training is recommended alongside medical weight loss programs. Preserving or building muscle mass during weight loss helps maintain metabolic rate and reduces the severity of metabolic adaptation over time.
Over time, some patients notice that the appetite-suppressing effects of semaglutide feel less pronounced than they did when treatment first began. This does not necessarily mean the medication is less effective. It may reflect the body’s partial adaptation to the medication’s appetite signaling, or it may reflect a dose that is appropriate for the initial phase of weight loss but needs adjustment as the clinical picture evolves.
The body defends a weight range it considers normal through multiple hormonal and neurological mechanisms. As you move further from your starting weight, the body’s drive to restore that weight increases. Leptin levels fall as fat mass decreases, reducing the signal that the body has adequate energy stores. Ghrelin levels rise, increasing hunger. These responses can partially counteract semaglutide’s appetite effects and contribute to a plateau.
According to research published in the New England Journal of Medicine, even participants in high-dose semaglutide trials experienced a slowing of weight loss over time as physiological adaptation occurred, with most weight loss occurring in the first 60 weeks and the rate of loss decreasing thereafter.
During a plateau, your body is not simply stopping weight loss arbitrarily. It is actively working to restore energy balance through the adaptive mechanisms described above. Understanding this helps reframe a plateau from failure to a predictable physiological event that requires a strategic response.
Your body is reducing energy expenditure to match reduced intake. It is increasing hunger signaling to drive food intake upward. It is conserving fat stores as a protective mechanism. None of these responses are pathological. They are the result of millions of years of evolutionary programming that was designed for survival in environments where food was scarce, not for weight management in modern conditions.
Semaglutide addresses several of these mechanisms, but it does not override all of them indefinitely without adjustment. This is why weight loss plateaus are not unique to semaglutide and why addressing them requires a multi-pronged response rather than simply waiting.
Before concluding that you have hit a genuine plateau on semaglutide, it is worth honestly evaluating several factors that can mimic a plateau without representing true physiological adaptation.
Has your dose been optimized? Many patients reach their target dose gradually over several months. If you are still on a lower dose and have not yet reached the therapeutic dose associated with maximum appetite suppression, dose progression may resolve the apparent stall without any other changes.
Has calorie intake crept upward? Portion sizes can increase gradually without conscious awareness. Food choices that feel similar to earlier in treatment may be higher in calories than assumed. A brief period of food tracking can reveal whether intake has drifted higher than intended.
Has physical activity decreased? Reduced activity without reduced intake narrows or eliminates a caloric deficit. Changes in work schedule, injury, seasonal shifts in activity, or reduced motivation can all produce a stall that is explained by activity rather than medication effectiveness.
Are you drinking enough water? Adequate hydration supports metabolic function and can affect the scale through water retention patterns. Insufficient water intake is not a major cause of plateaus but is worth addressing as part of an overall assessment.
Has anything changed in medications or health status? Several medications and health conditions can influence weight and metabolism. Changes in thyroid function, new medication additions, and other health factors can contribute to a stall that is not explained by semaglutide’s effectiveness.
Once a genuine plateau has been identified, several approaches can help break through it.
A recalibrated assessment of caloric intake relative to your current body weight and activity level is the most important first step. The maintenance calories at your current weight are lower than they were at your starting weight, which means what was previously a deficit may now be maintenance or even a slight surplus.
Working with your provider to establish a recalibrated target based on your current weight and activity level gives you a more accurate baseline to work from.
Adding resistance training if you are not already doing it, or increasing the intensity or frequency of existing exercise, can elevate energy expenditure and provide a stimulus for continued body composition improvement even when the scale is stalled. Muscle gained through resistance training may not show on the scale but improves metabolic rate and body composition measurably.
Adequate protein intake supports muscle preservation during weight loss, promotes satiety, and has a higher thermic effect than fat or carbohydrates. Ensuring your protein intake is sufficient relative to your body weight and activity level can support both continued fat loss and metabolic rate preservation during a plateau.
If you have not yet reached the maximum approved dose and have been tolerating the medication well, discussing dose progression with your provider is a straightforward and often effective option. Higher doses of semaglutide are associated with greater appetite suppression and weight loss in clinical trials.
For some patients, transitioning from semaglutide to tirzepatide, which targets both GLP-1 and GIP receptors, produces additional weight loss progress after a plateau. This is a decision to make with your provider based on your full clinical picture, adherence history, and response to current treatment.
If you are managing your care through a medical weight loss program, these conversations are a standard part of ongoing treatment rather than exceptional circumstances. Your provider is the right person to evaluate which adjustment makes the most sense given your specific situation.
You should contact your provider if your weight loss has stalled for four or more weeks despite consistent adherence, if you have noticed a significant return of appetite that is interfering with your ability to follow your treatment plan, if you are experiencing new or worsening symptoms that may be affecting your metabolism, or if you are considering making changes to your medication without guidance.
Do not stop semaglutide without consulting your provider first. Stopping abruptly can cause a rapid return of appetite and weight regain that is more difficult to address than the plateau itself.
For patients accessing care through out-of-state telehealth consultations, a follow-up virtual appointment to discuss a plateau is straightforward and does not require traveling to a clinic. Your provider can review your current dose, labs, and adherence factors virtually and recommend adjustments based on your current situation.
Most providers define a plateau as four or more weeks without meaningful weight loss despite consistent adherence. Short stalls of one to two weeks are common and often related to temporary water retention, hormonal fluctuations, or other non-physiological factors. Patience for the first two to three weeks of a stall is appropriate before concluding that a genuine plateau has occurred.
Semaglutide does not simply stop working, but its effects on weight loss tend to slow as physiological adaptation occurs and as the body approaches a new equilibrium. This is a predictable pattern rather than a medication failure. Dose optimization, lifestyle adjustments, and in some cases medication changes can address this slowing.
Small fluctuations of one to two pounds during a plateau are normal and related to water retention, digestive content, and hormonal cycles rather than true fat gain. A consistent upward trend over multiple weeks, however, warrants a conversation with your provider.
Yes. Chronic stress elevates cortisol, which promotes fat storage and increases appetite, partially counteracting semaglutide’s effects. If a plateau coincides with a period of elevated stress, addressing the stress is as clinically relevant as any medication adjustment.
Intermittent fasting can be a useful tool for some patients experiencing a plateau, but it is not appropriate for everyone and should be discussed with your provider before implementing. For patients on semaglutide, appetite suppression already makes extended fasting more manageable than it might otherwise be, but the approach needs to fit your overall health status and treatment plan.
Thyroid dysfunction, particularly hypothyroidism, can significantly impair metabolism and contribute to weight loss stalls. If you have not had thyroid function evaluated recently and are experiencing a persistent plateau, asking your provider to include thyroid labs in your next panel is a reasonable step. Addressing hypothyroidism alongside your medical weight loss program may be an important component of breaking through the plateau.
A weight loss plateau on semaglutide is a normal and predictable part of the treatment process, not a sign of failure or medication ineffectiveness. Plateaus occur because the body adapts metabolically to weight loss through reduced resting energy expenditure, increased hunger signaling, and set point defense mechanisms. Before concluding that a true plateau has occurred, it is worth honestly evaluating whether calorie intake, activity level, or dose optimization may explain the stall. When a genuine plateau is identified, practical responses include recalibrating caloric targets, increasing or varying physical activity, optimizing protein intake, discussing dose adjustment with your provider, and in some cases evaluating whether a medication change is appropriate. The most important step in any plateau is communication with your provider rather than independent changes to your treatment plan.
If you are experiencing a weight loss plateau on semaglutide and are not sure what to do next, a follow-up consultation with your provider is the most direct path to a personalized response. Learn more about how medical weight loss programs manage plateaus and long-term treatment progression. For patients outside of Maryland, out-of-state consultation options are available across multiple licensed states.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. The content is not intended to diagnose, treat, cure, or prevent any medical condition. Always consult a qualified healthcare provider before starting, stopping, or modifying any medication or treatment plan. Individual results and risks vary based on personal health history and clinical factors.
What Happens to Estrogen Levels When You Start TRT? June 14, 2026 10 min read Testosterone Replacement Therapy Table of
What Is Insulin Resistance and Why Does It Make Weight Loss So Hard? June 21, 2026 10 min read Medical
What Is Food Noise and How Do GLP-1 Medications Help Quiet It? May 24, 2026 10 min read Medical Weight
Can Poor Sleep Actually Cause Weight Gain? What the Research Shows Most conversations about weight loss focus on two things:
Currently only accepting new clients from: New Mexico, Utah, Minnesota, Maryland, Virginia, Delaware, Colorado, West Virginia, Arizona, Iowa, Florida, Nevada, and Connecticut.